lists the 25 psychotropic agents most fre quently mentioned. They accounted for virtually fourfifths of all psychotropic mentions.
An extremely important issue in health and social policy is the use of medications having significant poten tial for addiction or habituation, especially because the use of such agents also creates the risk of diversion into K e e illicit channels. Because of these factors they are treated s controlled substances and placed under the regula ry authority of the U.S. Drug Enforcement Adminis ation. The special sensitivi~ of the psychotropic series is evident in the NAMCS findings. More than one-half (56 percent) of all psychotropic mentions entailed the use of a controlled drug.
Because most of the psychotropic agents are under regulatory control, it comes as no surprise that there were no over-the-counter drugs among their members. The use of all psychotropic required a formal prescrip tion by the physician. About 9 of every 10 psychotropic were prescribed by trade name. Only a relatively minor proportion (13 percent) were combination drugs, the most frequently mentioned combinations involving the addition of an analgesic ingredient to an anti-anxiety base.
Diagnosis
Proper evaluation of the patterns of psychotropic utilization requires that the data user look first to the conditions that the drugs were intended to prevent or treat. The most direct and frequent linkage occurs here. A psychotropic agent is seldom if ever utilized for the sole reason that the patient is over 65 years or a femal~ or that the physician is a general practitioner or a psy hiatrist. It is fimdarnental then to examine the use of sychotropics in terms of the diagnoses rendered in ofilce-based care. The rate of psychotropic utilization as it varied among the major diagnostic groups and with the general nature of the patient's problem is shown in table 2. Apart from the class of mental disorders, which sui generis command the highest rate of all psychotropic utilization, four other diagnostic classes exceeded the average utilization rate of 69 mentions per 1,000 visits. They are � Symptoms, signs, and ill defined conditions � Diseases of the circulatory system � Diseases of the digestive system � Diseases of the musculoskeletal system For these "nonmental" disorders it is the use of the Category I drugs that most clearly causes the aboveaverage rates.
When the diagnostic findings are subjected to a finer scrutiny, the following speciiic diagnoses were found to be most frequently associated with psychotropic therapy From the preceding correlations between diagnosis and psychotropic utilization it is clear that the use ofpsych~ tropic therapy is most frequently associated with the chronic conditions (table 2) . With the acute conditions it is much less common. With nonillness care and with the post-traumatic conditions of surgery or injury, the use of psychotropic drugs is extremely modest.
Patient characteristics
From its lowest level, for patients under 25 years, the office-based utilization of psychotropic drugs accel erates sharply in successive age groups until it reaches its highest point among middle-aged patients in the age group 45-54 years. It then begins a gradual, if fluctuat in~ descent among patients in the remaining years of life (table 3 and figure 2 ).
This pattern applies to each of the psychotropic sub -categories, in large part reflecting the corresponding patterns of morbidity revealed by NAMCS diagnostic findings. For example, mental disorders, the conditions which command the highest rate of psychotropic usage, are proportionately most evident among oflce patients in the age group 30-50 years.
It is clear from the findings that female utilization of office-based, psychotropic therapy substantially ex ceeded its utilization by male patients (table 3). The imbalance favoring female patients lay ahnost entirely in the use of drugs in Categories I and II. For the antipsychotic and antimanic agents there was little or no difference between the sexes.
The sex-age findings show the age intervals in which the sex differences in psychotropic utilization become most manifest (table 4). Up to the 45th year, the general rate of utilization is equivalent for females and males. From the 45th year on, however, the rates diverge dra matically. In the age group 45-64 years, the female rate is roughly one-third again as high as the male rate in the age group 65 and over, it exceeds the male rate by almost 60 percent.
These findings correlate positively with NAMCS diagnostic evidence. For example, mental disorders and essential hypertensio~ the conditions that command the highest rate of psychotropic utilization, were pr~ portionately more frequent among the older female pa tients than among males.
Although overall psychotropic usage did not vary signillcant.ly between black and white office patients (table 4), the below-average use of antidepressants by blacks is an interesting finding, and one not clearly explicable by diagnostic correlates. (Black office pa tients show about the same proneness to depressive conditions as their white counterparts.) However, they visited the psychiatrist with only on~third the frequency of white patients, a fact that may partly explain the seeming anomaly. As evidenced by the findings, psy chiatrists' use of antidepressants substantially exceed their use by other physicians ( 
Prescriber characteristics
Among office-based specialists it was, of course, psychiatrists who showed the highest rate of psych otropicutilization, especially of the Category II and III agents (table 5) . After all, a substantial part of their professional effort is associated with those disorders that other specialist tend to refer for treatment, among them depressive conditions, schizophrenic disorders, and affective psychoses.
What may be surprising about the findings, as shown in table 5, is the extent that two primary care providers, the general practitioner and the internist, were involved in the utilization of ps ychotropic drugs. In sheer numbers of mentions they accounted for 66 percent of all Cate gory I drugs used in office-based practice, 59 percent of the Category 11drugs, and even a substantial 45 percent of the Category 111drugs. Their above-average rates o psychotropic utilization appear to stem less from thei clinical involvement with the mental disorders than a from their treatment of the other diagnostic groups that invite the use of psychotropics, notably symptoms, signs, and ill-defined conditions; and the circulatory, digestive, and musculoskeletal disease groups. About 30 percent of all visits to the general practitioner and45 percent of all the internists' visits were associated with one of these "nonmetal',' disease groups. Among the most-visited specialties, the lowest rates in psychotropic utilization occurred among the special ists with the largest proportion of nonillness care, the pediatrician and the obstetrician and/or gynecologist.
The differences in psychotropic utilization between doctors of medicine and doctors of osteopathy (table 5) probably reflect the fact that a clear majority of osteo pathic physicians are in general practice. The general practitioners, as already noted, well exceed the average in their use of psychotropic agents.
Other visit characteristics
An examination of the utilization rates reveals that the new patient is much less likely to receive psychoepic drug therapy than the patient whom the doctor Of as seen before (table 6). This is especially true if the new patient has been referred by another physician. In fact, the findings suggest that a newproblem-whether it is one presented by a new patient or one appearing for the f~st time in an old patient-will probably result in a use of psychotropic agents that is considerably below average. Thus newness of patient or problem (or both) seems to invite a more conservative approach toward psychotropic therapy by the prescribing physician.
Not only does this conservatism prevail at the point of entry into office-based ambulatory care, it is also evident at the end point of the visit. Of those visits that involved the prescription of one psychotropic drug or more, by far the most frequent disposition instructiongiven the patient at 72 percent of visits-was to return at a specified time. (The average use of this instruction in office practice is 60 percent.) Although such specitlcity of return instruction was probably strongly influenced by the nature and potential seriousness of the patient's problem, it seems also to reflect a commendable desire by the physician to maintain a closer than usual surveillance on a family of drugs that has its own unique hazards of use.
Co-occurrence
Utilized at 62 percent of oflice visits, drug therapy (of all types) is by far the most frequent form of treat ment provided in ofllce practice. Its magnitude is com- pounded by the finding that physicians, when they do use a drug, tend to use more than one. The overall average is about two drugs per drug visit, but larger multiples are not uncommon, especially when the pa tient suffers from more than one disorder. With co occurrence the rule rather than the exception, it is inter esting-indeed mandatory-to explore the patterns of concomitant utilization of drugs, for herein lies the poten tial for harmful as well as helpful interactions.
In table 7 is shown the extent to which psychotropic drugs c~occur with drugs in other therapeutic families, and the ,co-occurrence that exists among the psycho tropic subcategories themselves.
At the 69.3 million visits at which a psychotropic agent was utilized, its use (expressed as a percent of these visits) co-occurred most frequently with the use of one member or more of the following eight thera peutic families: Within the psychotropic family itself, the most fre quent co-occurrences existed among drugs in Categorie I and II (at 3.5 million visits); next among Category and HI drugs (at 1.8 million visits). The least frequen* pattern of c~occurrence was found among the drugs in Categories I and 111(at 1.4 million visits). -----ackincedata 9
Technical notes @ a
Source of data and sample design
The estimates presented in this report are based on the findings of the National Ambulatory Medical Care Survey (NAMCS), a sample survey of office-based care conducted annually from 1973 through 1981 by the National Center for Health Statistics. The target universe of NAMC S is composed of office visits made by ambulatory patients to non-Federal and noninsti tutional physicians who are principally engaged in officebased, patient-care practice. Visits to physicians prac ticing in Alaska and Hawaii are excluded from the range of NAMCS, as are visits to anesthesiologists, pathol~ gists, and radiologists.
NAMCS uses a multistage probability sample design that involves a stepwise sampling of primary sampling units (P SU'S), physicians' practices within PSU'S, and patient visits within physicians' practices. The physician sample (5,805 for 1980 and 198 1) was selected from master files maintained by the American Medical ASSG ciation and the American Osteopathic Association. Those members of the sample who proved to be inscope d eligible participated at a rate of 77.3 percent. Re onding physicians completed visit records for a sys ematic random sample of their office visits made during a randomly assigned weekly reporting period. Telephone contacts were excluded. During 1980 and 1981 respond ing physicians completed 89,447 visit records on which they recorded 97,796 drug mentions. Characteristics of the physician's practice, such as primary specialty and type of practice, were obtained during an induction interview. The National Opinion Research Center, un der contract to the National Center for Health Statistics, was responsible for the field operations of the survey.
Sampling errors and rounding
The standard error is a measure of the sampling variability that occtis by chance because only a sample, rather than the entire universe, is surveyed. The relative standard error of an estimate is obtained by dividing the standard error by the estimate itself and is expressed as a percent of the estimate. In this report, any estimate that exceeds a relative standard error of 30 percent is marked with an asterisk. Table I should be used to obtain the relative standard error for aggregates of office visits or for mentions of drugs by specflc name (for example, Valium). Table 11should be used to obtain the lative standard error for drug mentions expressed as g groups (for example, the psychotropic drug family).
In the tables of this report estimates have been rounded to the nearest thousand. Forthis reason, detailed estimates do not always add to totals. 
4.1
Example of use oftabla: An aggregate estimate of30,000,000 drug mentions has a relative standard error of 7.0 percent or a standard error of 2,100,00 mentions (7.0 percent of 30,000,000 mentions).
Definitions
An ojfce is a place that physicians identify as a location for their arnbulato~ practice. Responsibility for patient care and professional services rendered there resides with the individual physician rather than an institution.
A visit is a direct personal exchange between an ambulatory patient seeking health care and a physician, or staff member working under the physician's supervision, who provides the health services.
A drug mention is the physician's entry on the visit record of a pharmaceutical agent ordered or provided by any route of administration for prevention, diag nosis, or treatment. Generic as well as brand-name drugs are included, as are nonprescription as well as prescription drugs. The physician records all new drugs, and continued medications when the patient is specifically instructed during the visit to continue the medication.
An acuteproblem is a morbid condition with a rel tively sudden or recent onset (within 3 months of th 9 visit).
A chronic problem, routine is a morbid condition that existed for 3 months or more before the visit. The care indicated is of a regular, maintenance nature.
A chronicproblem, $are up is a sudden exacerbation of a preexisting chronic condition.
Nonilbzess care denotes health examinations and care provided for presumably healthy persons. Exam ples are: prenatal and postnatal care, annual physicals, well-child examinations, and insurance examinations. 
